Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice

[1]  M. Huguier,et al.  La Haute autorité de Santé (HAS) , 2013 .

[2]  J. Coquart,et al.  Emergency reversal of anticoagulation: the real use of prothrombin complex concentrates: a prospective multicenter two year French study from 2006 to 2008. , 2012, Thrombosis research.

[3]  D. Poli,et al.  The Practical Management of Intracerebral Hemorrhage Associated with Oral Anticoagulant Therapy , 2011, International journal of stroke : official journal of the International Stroke Society.

[4]  R. V. van Hest,et al.  Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy , 2011, Transfusion medicine.

[5]  W. Ageno,et al.  Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. , 2011, Blood transfusion = Trasfusione del sangue.

[6]  M. Makris,et al.  Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal? , 2011, Blood transfusion = Trasfusione del sangue.

[7]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.

[8]  G. Pernod,et al.  French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding). , 2010, Thrombosis research.

[9]  J. Suarez,et al.  Prothrombin Complex Concentrates for Oral Anticoagulant Therapy-Related Intracranial Hemorrhage: A Review of the Literature , 2010, Neurocritical care.

[10]  B. Vigué.  Bench-to-bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage – from theory to practice , 2009, Critical care.

[11]  F. Testai,et al.  Correction of coagulopathy in warfarin associated cerebral hemorrhage , 2009, Current opinion in critical care.

[12]  Mark Crowther,et al.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). , 2008, Chest.

[13]  W. Freeman,et al.  Management of warfarin-related intracerebral hemorrhage , 2008, Expert review of neurotherapeutics.

[14]  C. Leissinger,et al.  Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature , 2008, American journal of hematology.

[15]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[16]  Susan Regan,et al.  Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation , 2007, Circulation.

[17]  Michael D Hill,et al.  Determinants of Intracerebral Hemorrhage Growth: An Exploratory Analysis , 2007, Stroke.

[18]  D. Benhamou,et al.  Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage , 2007, Intensive Care Medicine.

[19]  J. Broderick,et al.  The increasing incidence of anticoagulant-associated intracerebral hemorrhage , 2007, Neurology.

[20]  W. Ageno,et al.  Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms , 2006, Journal of thrombosis and haemostasis : JTH.

[21]  M. Kaste,et al.  Recommendations for the Management of Intracranial Haemorrhage – Part I: Spontaneous Intracerebral Haemorrhage , 2006, Cerebrovascular Diseases.

[22]  G. Chang.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.

[23]  S M Davis,et al.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.

[24]  John Spandorfer,et al.  Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. , 2006, Archives of internal medicine.

[25]  Eric E. Smith,et al.  Timing of Fresh Frozen Plasma Administration and Rapid Correction of Coagulopathy in Warfarin-Related Intracerebral Hemorrhage , 2006, Stroke.

[26]  T. Steiner,et al.  Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy: Current Practices and Unresolved Questions , 2006, Stroke.

[27]  R. Hart,et al.  Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas , 2005, Stroke.

[28]  Margaret C Fang,et al.  Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation , 2004, Annals of Internal Medicine.

[29]  J. Hanley.  Warfarin reversal , 2004, Journal of Clinical Pathology.

[30]  S. Greenberg,et al.  Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage , 2004, Neurology.

[31]  D. Singer,et al.  The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. , 2004, Archives of internal medicine.

[32]  James Douketis,et al.  Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism , 2003, Annals of Internal Medicine.

[33]  S. Ridley,et al.  Drugs in anaesthesia , 2003, Anaesthesia.

[34]  H. Naritomi,et al.  Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose , 2003, Annals of Hematology.

[35]  David A Fitzmaurice,et al.  ABC of antithrombotic therapy : Bleeding risks of , 2002 .

[36]  B. Norrving,et al.  Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter Study , 2001, Stroke.

[37]  S. Mörsdorf,et al.  The use of prothrombin complex concentrates in the treatment of hemorrhages induced by oral anticoagulation. , 1999, Thrombosis research.

[38]  M. Köhler.  Thrombogenicity of prothrombin complex concentrates. , 1999, Thrombosis research.

[39]  R. Beyth,et al.  Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. , 1998, The American journal of medicine.

[40]  F. Rosendaal,et al.  Emergency Oral Anticoagulant Reversal: The Relative Efficacy of Infusions of Fresh Frozen Plasma and Clotting Factor Concentrate on Correction of the Coagulopathy , 1997, Thrombosis and Haemostasis.

[41]  Vittorio Pengo,et al.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.

[42]  J. Vandenbroucke,et al.  Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.

[43]  E. Hylek,et al.  Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[44]  Loeliger Ea.  [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery]. , 1993 .

[45]  J. Houben,et al.  [No advantage in the addition of dipyridamole or of oral anticoagulants in comparison to low-dose acetylsalicylic acid (50 mg per day) in the prevention of venous transplant occlusion following coronary bypass surgery]. , 1993, Nederlandsch tijdschrift voor geneeskunde.

[46]  J. Broderick,et al.  Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.

[47]  B. Norrving,et al.  Emergency Reversal of Anticoagulation After Intracerebral Hemorrhage , 1992, Stroke.

[48]  G. Harbauer,et al.  Comparison of different prothrombin complex concentrates--in vitro and in vivo studies. , 1990, Thrombosis research.

[49]  J. V. van Swieten,et al.  Intracerebral hematomas during anticoagulant treatment. , 1990, Stroke.

[50]  J. Miller,et al.  Traumatic acute subdural hematoma: major mortality reduction in comatose patients treated within four hours. , 1981, The New England journal of medicine.

[51]  S. Mayer,et al.  Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. , 2007, Mayo Clinic proceedings.

[52]  P. Strengers,et al.  Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. , 2006, Thrombosis research.

[53]  J. Broderick,et al.  Location and outcome of anticoagulant-associated intracerebral hemorrhage , 2006, Neurocritical care.

[54]  H. Naritomi,et al.  Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation. , 2005, Thrombosis research.